Cardiovascular involvement in patients with different causes of hyperthyroidism

Bernadette Biondi1, George J Kahaly

  • 1Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy. bebiondi@unina.itbebiondi@libero.it

Insights

Hyperthyroidism increases cardiovascular risks, with toxic multinodular goiter posing a higher risk than Graves disease. Understanding the cause of hyperthyroidism is crucial for managing cardiac complications.

Area of Science:

  • Endocrinology
  • Cardiology
  • Internal Medicine

Background:

  • Hyperthyroidism, a condition of overactive thyroid, presents with varied effects based on patient age, disease severity, and comorbidities.
  • Cardiovascular disease is a significant cause of morbidity and mortality in hyperthyroid patients, but the link between specific cardiac complications and hyperthyroid etiology is not well-defined.

Purpose of the Study:

  • To compare the cardiovascular risks associated with different causes of hyperthyroidism, specifically Graves disease, toxic adenoma, and toxic multinodular goiter.
  • To investigate how patient age and the specific etiology of hyperthyroidism influence cardiovascular complications.

Main Methods:

  • Comparative analysis of cardiovascular risks in patients with Graves disease, toxic adenoma, and toxic multinodular goiter.
  • Review of clinical data focusing on age, comorbidities, and specific cardiovascular outcomes.

Main Results:

  • Patients with toxic multinodular goiter exhibit a higher cardiovascular risk compared to those with Graves disease.
  • Atrial fibrillation, atrial enlargement, and congestive heart failure are common in older patients (≥60 years) with toxic multinodular goiter, especially those with pre-existing heart conditions.
  • Graves disease is associated with autoimmune-related cardiac issues, including valve involvement, pulmonary arterial hypertension, and cardiomyopathy.

Conclusions:

  • The specific cause of hyperthyroidism significantly impacts cardiovascular risk and complication profiles.
  • Establishing the etiology of hyperthyroidism is essential for tailoring treatment strategies for both the thyroid condition and its associated cardiovascular manifestations.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
59
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
49
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
33
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
35